OSR Health Faces Nasdaq Delisting; Trading Suspension Set for August 26
OSRH sits 38% above its 52-week low of $0.251 on elevated volume (2.2× avg).
Summary
OSR Health received a Nasdaq delisting determination and faces trading suspension on August 26, 2026. The company plans to appeal, but the suspension will proceed regardless.
Key Events · Legal and Risk Events · OSRH
-
Nasdaq Delisting Determination
On August 19, 2026, OSR Health received a Staff Delisting Determination from Nasdaq for failing to regain compliance with the $1.00 minimum bid price requirement.
-
Trading Suspension Scheduled
Trading in OSRH common stock and OSRHW warrants will be suspended at the opening of business on August 26, 2026.
-
Hearing Request Planned
The company intends to request a hearing before a Nasdaq Hearings Panel by 4:00 p.m. ET on August 26, 2026, but the request will not stay the trading suspension.
-
Extraordinary Trading Volume
On August 17, 2026, OSRH ranked #1 in Most Active Share Volume across all of Nasdaq with approximately 370 million shares traded, followed by 145 million shares on August 18.
Analysis · OSRH · Industrial Applications And Services
A Nasdaq Staff Delisting Determination was issued to OSR Health on August 19, 2026, after the company failed to regain compliance with the $1.00 minimum bid price requirement. Trading in its common stock and warrants will be suspended at the opening of business on August 26, 2026. The company intends to request a hearing before a Nasdaq Hearings Panel, but a timely request will not stay the suspension. This is a critical event that threatens the company's exchange listing and could severely impact liquidity and investor confidence.
At the time of this filing, OSRH was trading at $0.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $13.1M. The 52-week trading range was $0.25 to $1.24. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.